Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain

  1. Yuan Zhu1,
  2. Mario I. Romero1,
  3. Pritam Ghosh1,
  4. Zhengyi Ye2,
  5. Patrick Charnay3,
  6. Elizabeth J. Rushing4,
  7. Jamey D. Marth2, and
  8. Luis F. Parada1,5
  1. 1Center for Developmental Biology and Kent Waldrep Foundation Center for Basic Research on Nerve Growth and Regeneration, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9133, USA; 2Howard Hughes Medical Institute, University of California San Diego, La Jolla, California 92093, USA; 3Ecole Normale Superieure, Paris, France; 4Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9133, USA

Abstract

Neurofibromatosis type 1 (NF1) is a prevalent genetic disorder that affects growth properties of neural-crest-derived cell populations. In addition, approximately one-half of NF1 patients exhibit learning disabilities. To characterize NF1 function both in vitro and in vivo, we circumvent the embryonic lethality of NF1 null mouse embryos by generating a conditional mutation in the NF1 gene usingCre/loxP technology. Introduction of a Synapsin I promoter driven Cre transgenic mouse strain into the conditional NF1 background has ablated NF1 function in most differentiated neuronal populations. These mice have abnormal development of the cerebral cortex, which suggests that NF1 has an indispensable role in this aspect of CNS development. Furthermore, although they are tumor free, these mice display extensive astrogliosis in the absence of conspicuous neurodegeneration or microgliosis. These results indicate that NF1-deficient neurons are capable of inducing reactive astrogliosis via a non-cell autonomous mechanism.

Keywords

Footnotes

  • 5 Corresponding author.

  • E-MAIL luis.parada{at}utsouthwestern.edu; FAX (214) 648-1960.

  • Article and publication are at www.genesdev.org/cgi/doi/10.1101/gad.862101.

    • Received October 25, 2000.
    • Accepted January 31, 2001.
| Table of Contents

Life Science Alliance